Skip to main content

Antepartum Management of Women with Cardiovascular Disease

  • Chapter
  • First Online:
Maternal and Fetal Cardiovascular Disease
  • 470 Accesses

Abstract

Cardiac disease is a major cause of maternal death. The number of such cardiac patients at risk is expected to grow. Women with pulmonary hypertension, severe left ventricular outflow stenosis, cyanotic congenital heart disease, aortic root dilatation, cardiac dysfunction, and mechanical valves have a high risk. The most frequent complications during pregnancy and delivery are heart failure and arrhythmias. Risk stratification for pregnancy and heart disease relates to the functional status of the patient and is lesion specific. Timely prepregnancy counseling should be offered to all women with heart disease in order to prevent avoidable pregnancy-related risks. Adequate care during pregnancy, delivery, and the postpartum period requires a multidisciplinary team approach with cardiologists, obstetricians, and anesthesiologists and other related disciplines. Successful pregnancy is feasible for most women with heart disease with a relatively low risk when appropriate counseling and optimal care are provided.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Niwa K, Aomi S, Akagi T, et al Diagnosis and treatment of cardiovascular diseases (2009 Joint Working Groups Report). Guidelines for indication and management of pregnancy and delivery in women with heart disease (JCS 2010, revised). http://www.j-circ.or.jp/guideline/pdf/JCS2010niwa.h.pdf

  2. JCS Joint Working Group (2012) Guidelines for indication and management of pregnancy and delivery in women with heart disease (JCS 2010) digest version. Circ J 76:240–260

    Article  Google Scholar 

  3. Gelson E, Ogueh O, Johnson M (2006) Cardiac changes in normal pregnancy. In: Steer PJ, Gatzoulis MA, Baker P (eds) Heart disease and pregnancy. RCOG Press, London, pp 29–44

    Google Scholar 

  4. Mabie WC, DiSessa TG, Crocker LG et al (1994) A longitudinal study of cardiac output in normal human pregnancy. Am J Obstet Gynecol 170:849–856

    Article  CAS  PubMed  Google Scholar 

  5. Poppas A, Shroff SG, Korcarz CE et al (1997) Serial assessment of the cardiovascular system in normal pregnancy. Circulation 95:2407–2415

    Article  CAS  PubMed  Google Scholar 

  6. Niwa K, Perloff JK, Bhuta SM et al (2001) Structural abnormalities of great arterial walls in congenital heart disease: light and electron microscopic analyses. Circulation 103:393–400

    Article  CAS  PubMed  Google Scholar 

  7. Katsuragi S, Ueda K, Yamanaka K et al (2011) Pregnancy-associated aortic dilatation or dissection in Japanese women with Marfan syndrome. Circ J 75:2545–2551

    Article  PubMed  Google Scholar 

  8. Niwa K, Tateno S, Akagi T et al (2007) Arrhythmia and reduced heart rate variability during pregnancy in women with congenital heart disease and previous reparative surgery. Int J Cardiol 122:143–148

    Article  PubMed  Google Scholar 

  9. Ohuchi H, Tanabe Y, Kamiya C et al (2013) Cardiopulmonary variables during exercise predict pregnancy outcome in women with congenital heart disease. Circ J 77:470–476

    Article  PubMed  Google Scholar 

  10. Kamiya C, Nakatani S, Hashimoto S et al (2008) Role of echocardiography in assessing pregnant women with and without heart disease. J Echocardiogr 6:29–38

    Article  Google Scholar 

  11. Colman JM, Silversides CK, Sermer M et al (2006) Cardiac monitoring during pregnancy. In: Steer PJ, Gatzoulis MA, Baker P (eds) Heart disease and pregnancy. RCOG Press, London, pp 67–77

    Google Scholar 

  12. DeWilde JP, Rivers AW, Price DL (2005) A review of the current use of magnetic resonance imaging in pregnancy and safety implications for fetus. Prog Biophys Mol Biol 87:335–353

    Article  CAS  Google Scholar 

  13. Silka M, Hardy B, Menashe V et al (1998) A population-based prospective evaluation of risk of sudden cardiac death after operation for common congenital heart defects. J Am Coll Cardiol 32:245–251

    Article  CAS  PubMed  Google Scholar 

  14. Gatzoulis MA, Balaji S, Webber SA et al (2000) Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicenter study. Lancet 356:975–981

    Article  CAS  PubMed  Google Scholar 

  15. Shotan A, Ostrzega E, Mehra A et al (1997) Incidence of arrhythmias in normal pregnancy and relation to palpitations, dizziness, and syncope. Am J Caridiol 79:1061–1064

    Article  CAS  Google Scholar 

  16. Joglar JA, Page RL (2001) Antiarrhythmic drugs in pregnancy. Curr Opin Cardiol 16:40–45

    Article  CAS  PubMed  Google Scholar 

  17. Brodsky M, Doria R, Allen B et al (1992) New-onset ventricular tachycardia during pregnancy. Am Heart J 123:933–941

    Article  CAS  PubMed  Google Scholar 

  18. Tateno S, Niwa K, Nakazawa M et al (2003) Arrhythmia and conduction disturbances in patients with congenital heart disease during pregnancy – multicenter study. Circ J 67:992–997

    Article  PubMed  Google Scholar 

  19. Dalvi BV, Chaudhuri A, Kulkarni HL et al (1992) Therapeutic guidelines for congenital heart block presenting in pregnancy. Obstet Gynecol 79:802–804

    CAS  PubMed  Google Scholar 

  20. Egidy AG, Cassater D, Landzberg M et al (2013) The effects of pregnancy on right ventricular remodeling in women with repaired tetralogy of Fallot. Int J Cardiol 168:1847–1852

    Article  Google Scholar 

  21. Kamiya CA, Iwamiya T, Neki R et al (2012) Outcome of pregnancy and effects on the right heart in women with repaired tetralogy of Fallot. Circ J 76:957–963

    Article  PubMed  Google Scholar 

  22. Siu SC, Sermer M, Harrison DA et al (1997) Risk and predictors for pregnancy-related complications in woman with heart disease. Circulation 96:2789–2794

    Article  CAS  PubMed  Google Scholar 

  23. Buttar HS (1997) An overview of the influence of ACE inhibitors on fetal-placental circulation and perinatal development. Mol Cell Biochem 176:61–71

    Article  CAS  PubMed  Google Scholar 

  24. Cooper WO, Hernandez-Diaz S, Arbogast PG et al (2006) Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med 354:2443–2451

    Article  CAS  PubMed  Google Scholar 

  25. Presbitero P, Prever SB, Brusca A (1996) Interventional cardiology in pregnancy. Eur Heart J 17:182–188

    Article  CAS  PubMed  Google Scholar 

  26. Wloch A, Respondek-Liberska M, Sysa A et al (2004) Significant aortic and pulmonary valve stenosis in the prenatal period: diagnosis, treatment and outcome: a two-centre study. Acta Cardiol 59:242–243

    PubMed  Google Scholar 

  27. Parry AJ, Westaby S (1996) Cardiopulmonary bypass during pregnancy. Ann Thorac Surg 61:1865–1869

    Article  CAS  PubMed  Google Scholar 

  28. Colman JM, Sermer M, Seaward PG et al (2000) Congenital heart disease in pregnancy. Cardiol Rev 8:166–173

    Article  CAS  PubMed  Google Scholar 

  29. Child J, Perloff JK, Koos B (2009) Management of pregnancy and contraception in congenital heart disease. In: Perloff JK, Child JS, Aboulhosn J (eds) Congenital heart disease in adults, 3rd edn. Saunders/Elsevier, Philadelphia, pp 194–220

    Chapter  Google Scholar 

  30. Guidelines for the Diagnosis and Treatment of Cardiovascular Diseases (2007 Joint Working Groups Report) Guidelines for the Prevention and Treatment of Infective Endocarditis (JCS 2008). http://www.j-circ.or.jp/guideline/pdf/JCS2008_miyatake_h.pdf

  31. Stuart G (2006) Maternal endocarditis. In: Steer PJ, Gatzoulis MA, Baker P (eds) Heart disease and pregnancy. RCOG Press, London, pp 267–282

    Google Scholar 

  32. Child JS, Pegues DA, Perloff JK (2009) Infective endocarditis and congenital heart disease. In: Perloff JK, Child JS, Aboulhosn J (eds) Congenital heart disease in adults, 3rd edn. Saunders/Elsevier, Philadelphia, pp 168–193

    Chapter  Google Scholar 

  33. Siu SC, Sermer M, Colman JM et al (2001) Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation 104:515–521

    Article  CAS  PubMed  Google Scholar 

  34. Khairy P, Ouyang DW, Fernandes SM et al (2006) Pregnancy outcomes in women with congenital heart disease. Circulation 113:517–524

    Article  PubMed  Google Scholar 

  35. Siu SC, Colman JM, Sorensen S et al (2002) Adverse neonatal and cardiac outcomes are more common in pregnant women with cardiac disease. Circulation 105:2179–2184

    Article  PubMed  Google Scholar 

  36. Briggs GG, Freeman RK, Yaffe SJ (eds) (2008) Drugs in pregnancy and lactation, 8th edn. Lippincott Williams & Wilkins, Philadelphia

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Koichiro Niwa .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Science+Business Media Singapore

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Niwa, K. (2019). Antepartum Management of Women with Cardiovascular Disease. In: Ikeda, T., Aoki-Kamiya, C. (eds) Maternal and Fetal Cardiovascular Disease. Springer, Singapore. https://doi.org/10.1007/978-981-10-1993-7_1

Download citation

  • DOI: https://doi.org/10.1007/978-981-10-1993-7_1

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-10-1991-3

  • Online ISBN: 978-981-10-1993-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics